Cytokinetics Income Statement (2010-2026) | CYTK

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Revenue & cost
Revenue (Quarter)	5.44M	40.07M	1.15M	88.97M	2.52M	1.96M	4.61M	0.87M	0.38M	1.67M	0.83M	0.25M	0.46M	15.00M	1.58M	66.77M	1.94M	17.75M	19.36M	28.62M
Cost of Revenue (Quarter)																			0.16M	2.73M
Gross Profit (Quarter)															1.58M				19.20M	25.89M
Operating items
Research & Development (Quarter)	48.44M	43.50M	45.94M	57.13M	62.73M	75.02M	79.42M	83.19M	82.53M	84.98M	81.57M	79.60M	84.61M	93.63M	98.26M	112.55M	99.23M	104.40M	95.53M	97.81M
Selling, General & Administrative (Quarter)	26.20M	33.81M	33.07M	42.72M	48.22M	53.97M	49.66M	39.72M	40.11M	44.11M	45.50M	50.82M	56.65M	62.34M	57.37M	65.72M	69.46M	91.72M	104.90M	104.40M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)															1.58M				2.55M	5.59M
Operating Expenses (Quarter)	74.64M	77.30M	79.00M	99.84M	110.96M	128.99M	129.09M	122.92M	122.64M	129.09M	127.07M	130.42M	141.26M	155.97M	157.21M	178.28M	168.69M	196.12M	202.97M	207.80M
Operating Income (Quarter)	-69.20M	-21.70M	-77.86M	-10.87M	-108.44M	-127.03M	-124.47M	-122.05M	-122.27M	-127.42M	-126.23M	-130.17M	-140.80M	-139.04M	-155.63M	-111.51M	-166.75M	-178.37M	-183.62M	-179.17M
EBIT (Quarter)	-69.20M	-21.70M	-77.86M	-10.87M	-108.44M	-127.03M	-124.47M	-122.05M	-122.27M	-127.42M	-126.23M	-130.17M	-140.80M	-139.04M	-155.63M	-111.51M	-166.75M	-178.37M	-183.62M	-179.17M
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)			-2.69M		-22.25M							0.60M	-15.20M	1.30M	-0.40M	-3.00M	0.70M	13.30M	1.50M	2.40M
Non Operating Income (Quarter)	0.23M	-0.38M	0.41M	0.86M	4.14M	5.92M	6.42M	6.78M	6.84M	7.59M	7.91M	11.55M	17.05M	15.01M	13.70M	13.00M	10.25M	11.47M	11.02M	13.94M
Net income details
EBT (Quarter)	-113.32M	-26.48M	-84.42M	-13.68M	-115.25M	-140.89M	-131.43M	-129.09M	-129.40M	-116.57M	-136.44M	-142.90M	-149.73M	-148.56M	-165.28M	-122.59M	-188.89M	-175.96M	-185.20M	-183.25M
Tax Provisions (Quarter)
Profit After Tax (Quarter)	-76.13M	-31.37M	-89.44M	-19.82M	-142.31M	-135.41M	-131.29M	-128.64M	-129.42M	-136.90M	-135.64M	-143.32M	-160.54M	-153.01M	-161.38M	-134.37M	-306.18M	-182.44M	-208.27M	-200.98M
Income from Non-Controlling Interests (Quarter)	-0.04M	-0.80M	-2.72M	-0.91M	-1.06M	1.97M	1.95M	0.19M	0.58M	0.88M	-0.56M	-0.50M	6.54M	-3.33M	-0.54M	-0.85M	0.17M	0.23M	-1.84M	-1.77M
Income from Continuing Operations (Quarter)	-113.32M	-26.48M	-84.42M	-13.68M	-115.25M	-140.89M	-131.43M	-129.09M	-129.40M	-116.57M	-136.44M	-142.90M	-149.73M	-148.56M	-165.28M	-122.59M	-188.89M	-175.96M	-185.20M	-183.25M
Consolidated Net Income (Quarter)	-113.32M	-26.48M	-84.42M	-13.68M	-115.25M	-140.89M	-131.43M	-129.09M	-129.40M	-116.57M	-136.44M	-142.90M	-149.73M	-148.56M	-165.28M	-122.59M	-188.89M	-175.96M	-185.20M	-183.25M
Income towards Parent Company (Quarter)	-113.32M	-26.48M	-84.42M	-13.68M	-115.25M	-140.89M	-131.43M	-129.09M	-129.40M	-116.57M	-136.44M	-142.90M	-149.73M	-148.56M	-165.28M	-122.59M	-188.89M	-175.96M	-185.20M	-183.25M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-113.32M	-26.48M	-84.42M	-13.68M	-115.25M	-140.89M	-131.43M	-129.09M	-129.40M	-116.57M	-136.44M	-142.90M	-149.73M	-148.56M	-165.28M	-122.59M	-188.89M	-175.96M	-185.20M	-183.25M
Additional items
EPS (Basic) (Quarter)	-0.00M	-344.39	-993.23	-159.58	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M
EPS (Diluted) (Quarter)	-0.00M	-344.39	-993.23	-159.58	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M
Shares Outstanding (Quarter)	0.08M	0.08M	0.08M	0.09M	0.09M	0.09M	0.10M	0.10M	0.10M	0.10M	0.10M	0.11M	0.12M	0.11M	0.12M	0.12M	0.12M	0.12M	0.12M	0.13M
Shares Outstanding (Diluted) (Quarter)	0.08M	0.08M	0.08M	0.09M	0.09M	0.09M	0.10M	0.10M	0.10M	0.10M	0.10M	0.11M	0.12M	0.11M	0.12M	0.12M	0.12M	0.12M	0.12M	0.13M
Shares Outstanding (Entity) (Quarter)	0.08M	0.08M	0.08M	0.09M	0.09M	0.09M	0.10M	0.10M	0.10M	0.10M	0.10M	0.11M	0.12M	0.11M	0.12M	0.12M	0.12M	0.12M	0.12M	0.13M
EBITDA (Quarter)	-69.20M	-21.70M	-77.86M	-10.87M	-108.44M	-127.03M	-124.47M	-122.05M	-122.27M	-127.42M	-126.23M	-130.17M	-140.80M	-139.04M	-155.63M	-111.51M	-166.75M	-178.37M	-183.62M	-179.17M
Interest Expenses (Quarter)	44.12M	4.78M	6.56M	2.81M	6.80M	13.86M	6.96M	7.04M	7.14M	-10.85M	10.21M	12.73M	8.93M	9.52M	9.65M	11.08M	22.14M	-2.40M	1.58M	4.08M
Tax Rate (Quarter)

Research Tools

Datasets

Plans

Developers

Cytokinetics Income Statement (2010-2026) | CYTK

Research Tools

Datasets

Plans

Developers

Cytokinetics Income Statement (2010-2026) | CYTK

Create an account

Sign In

Reset Password